Major indexes posted all-time closing highs Thursday as technology stocks surged following news that Nvidia will invest in ...

The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

VIENNA (Reuters) -Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for ...

Eli Lilly and Company (NYSE: LLY) has been one of the best-performing stocks outside of the AI-enhanced Magnificent 7 stocks ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

In 2015, Julianne Moore won the Academy Award for Best Actress for her starring role in Still Alice, portraying a middle-aged woman diagnosed with early onset Alzheimer’s disease. A decade later, ...

The Virtus Silvant Focused Growth Fund returned +20.87% (Class INST) for the quarter, compared with the Russell 1000 Growth ...

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...

Novo Nordisk is “no longer the elephant in the room,” Berenberg analysts say. Eli Lilly may have to fight hard to keep its ...

Nvov Nordisk stock rose after a study showed Ozempic reduced the risk of heart attack, stroke and death by 23% compared with ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.